Gender-specific changes in bone turnover and skeletal architecture in Igfbp-2-null mice

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2051-2061

  DeMambro, Victoria E ^a   Clemmons, D R ^b   Horton, L G ^a   Bouxsein, M L ^c   Wood, T L ^d   Beamer, W G ^a   Canalis, E ^e   Rosen, Clifford J ^a  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BONE DENSITOMETRY; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; GLUCOSE TOLERANCE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; TRABECULAR BONE;

ANIMALS; AORTA; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; BONE REMODELING; CELLS, CULTURED; FEMALE; FEMUR; GLUCOSE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCALCIN; PTEN PHOSPHOHYDROLASE; SEX CHARACTERISTICS;

EID: 42449117625     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1068     Document Type: Article

References (47)

1. Ricort JM 2004 Insulin-like growth factor binding protein (IGFBP) signaling. Growth Horm IGF Res 14:277-286
2. Conover CA 2007 Insulin-like growth factor binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 294:E10-E14
3. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31
4. Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Anagnostopoulos A, Baldarelli RM, Baya M, Beal JS, Bello SM, Boddy WJ, Bradt DW, Burkart DL, Butler NE, Campbell J, Cassell MA, Corbani LE, Cousins SL, Dahmen DJ, Dene H, Diehl AD, Drabkin HJ, Frazer KS, Frost P, Glass LH, Goldsmith CW, Grant PL, Lennon-Pierce M, Lewis J, Lu I, Maltais LJ, McAndrews-Hill M, McClellan L, Miers DB, Miller LA, Ni L, Ormsby JE, Qi D, Reddy TB, Reed DJ, Richards-Smith B, Shaw DR, Sinclair R, Smith CL, Szauter P, Walker MB, Walton DO, Washburn LL, Witham IT, Zhu Y; Mouse Genome Database Group 2005 The Mouse Genome Database (MGD): from genes to mice: a community resource for mouse biology. Nucleic Acids Res 33:D471-D475
5. Ranke M, Maier K, Schweizer R, Stadler B, Schleicher S, Elmlinger M, Flehmig B 2003 Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma. Horm Res 60:174-180
6. Boulle N, Baudin E, Gicquel C, Logie A, Bertherat J, Penfornis A, Bertagna X, Luton JP, Schulumberger M, Le Bouc Y 2001 Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur J Endocrinol 144:29-36
7. Baxter RC 2001 Changes in the IGF-IGFBP axis in critical illness. Best Pract Res Clin Endocrinol Metab 15:421-434
8. Lee WH, Gaylord TD, Bowsher RR, Hlaing M, Moorehead H, Liechty EA 1997 Nutritional regulation of circulating insulin-like growth factors (IGFS) and their binding proteins in the ovine fetus. Endocr J 44:163-173
9. Smith WJ, Underwood LE, Clemmons DR 1995 Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinal Metab 80:443-449
10. Rivero F, Goya L, Ala'ez C, Pascual-Leone AM 1995 Effects of undernutrition and diabetes on serum and liver mRNA expression of IGFs and their binding proteins during rat development. J Endocrinol 145:427-440
11. McGuire MA, Bauman DE, Dwyer DA, Cohick WS 1995 Nutritional modulation of the somatotropin/insulin-like growth factor system: response to feed deprivation in lactating cows. J Nutr 125:493-502
12. Vicini JL, Buonomo FC, Veenhuizen JJ, Miller MA, Clemmons DR, Collier RJ 1991 Nutrient balance and stage of lactation affect responses of insulin, insulin-like growth factor-binding protein 2 to somatotropin administration in dairy cows. J Nutr 121:1656-1664
13. Straus DS, Takemoto CD 1990 Effect of dietary protein deprivation on insulin-like growth factor (IGF)- I and II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology 127:1849-1860
14. Donovan SM, Atilano LC, Hintz RL, Wilson DM, Rosenfeld RG 1991 Differential regulation of the insulin-like growth factors (IGF-I and II) and IGF binding proteins during malnutrition in the neonatal rat. Endocrinology 129:149-157
15. Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR 2006 Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Am J Physiol Endocrinol Metab 290:E1006-E1013
16. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
17. Grinspoon S, Miller K, Herzog D, Clemmons D, Klibanski A 2003 Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. J Clin Endocrinal Metab 88:1142-1149
18. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R, Wolf E 2001 Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142:1889-1898
19. Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, Reasner CA, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA 1998 Insulin-like growth factor abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest 101:2165-2173
20. Conover CA, Johnstone EW, Turner RT, Evans GL, Ballard FJ, Doran P, Khosla S 2002 Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral denisty in a rat model of disuse osteoporosis. Growth Horm IGF Res 12:178-183
21. Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S 2007 High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 22:799-807
22. Wood TL, Rogler LE, Czick ME, Schuller AGP, Pintar JE 2000 Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 14:1472-1482
23. Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M 2004 Congenic mice with low serum IGF-1 have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35:1046-1058
24. Rosen C, Churchill G, Donahue L, Shultz K, Burgess J, Powell D, Beamer W 2000 Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice. Bone 27:521-528
25. Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE, Beamer WG, Rosen CJ 2006 Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 147:3915-3923
26. Busby Jr WH, Nam TJ, Moralez A, Smith C, Jennings M, Clemmons DR 2000 The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. J Biol Chem 275:37638-37644
27. Nam TJ, Busby Jr W, Clemmons DR 1997 Insulin-like growth factor binds protein-5 binds to plasminogen activator inhibitor-I. Endocrinology 138:2972-2978
28. Haffa A, Krueger A, Bruner J, Engelke J, Gundberg C, Akhter M, Binkley N 2000 Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res 15:872-878
29. Beamer WG, Shultz KL, Ackert-Bicknell CL, Horton LG, Delahunty KM, Coombs III HR, Donahue LR, Canalis E, Rosen CJ 2007 Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. J Bone Miner Res 22:1187-1196
30. Rydziel S, Stadmeyer L, Zanotti S, Durant D, Smerdel-Ramoya A, Canalis E 2007 Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem 282:19762-19772
31. Paritt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Reckner RR 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR nomenclature committee. J Bone Miner Res 2:595-610
32. Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, Sawyers CL 2007 Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status ad PI3K/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci USA 104:5563-5568
33. He J, Rosen CJ, Adams DJ, Kream BE 2006 Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 38:826-835
34. Mohan S, Baylink DJ 2005 Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol 185:415-420
35. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
36. Roberts AJ, Funston RN, Moss GE 2001 Insulin-like growth factor binding proteins in the bovine anterior pituitary. Endocrine 14:399-405
37. Yamashita S, Melmed S 1986 Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 118:176-182
38. Zhou X, Herman JP, Paden CM 1997 Expression of insulin-like growth factor binding protein-2 during postnatal development of the rat neurointermediate pituitary. Neuroendocrinology 66:17-27
39. Wallenius K, Sjögen K, Peng XD, Park S, Wallenius V, Liu JL, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson JO 2001 Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142:4762-4770
40. Perks CM, Vernon EG, Rosendahl AH, Tonge D, Holly JM 2007 IGF-II and IGFBP-2 differentially regulated PTEN in human breast cancer cells. Oncogene 26:5966-5972
41. Sakata T, Wang Y, Halloran BP, Elalieh HZ, Cao J, Bikle DD 2004 Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways. J Bone Miner Res 19:436-446
42. Shoba LN, Lee JC 2003 Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity fetal rat calvaria cells. J Cell Biochem 88:1247-1255
43. Tian Q, He XC, Hood L, Li L 2005 Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3ζ. Cell Cycle 2:215-216
44. Zhao H, Cui Y, Dupont J, Sun H, Hennighausen L, Yakar S 2005 Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Cancer Res 65:6864-6873
45. Beck SE, Carethers JM 2007 BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther 6:1313-1317
46. Ford-Hutchison AF, Ali Z, Lines SE, Hallgrimsson B, Boyd SK, Jirik FR 2007 Inactivation of Pten in osteo-chrondroprogenitor cells leads to epiphyseal growth plates abnormalities and skeletal overgrowth. J Bone Miner Res 22:1245-1259
47. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO, Clemens TL 2007 Lifelong accumulation of bone in mice lacking PTEN in osteoblasts. Proc Natl Acad Sci USA 104:2259 -2264